Kenvue Inc.
Kenvue Inc. is an American consumer health company. Formerly the Consumer Healthcare division of Johnson & Johnson, Kenvue owns well-known brands such as Aveeno, Band-Aid, Benadryl, Zyrtec, Johnson's, Listerine, Lactaid, Mylanta, Neutrogena, Trosyd, Calpol, Tylenol, and Visine. Kenvue is incorporated in Delaware and was originally headquartered in the Skillman section of Montgomery Township, New Jersey, before relocating to Summit, New Jersey.
Basic company information
Each field links to its source. Financial figures retain their reporting periods; background references are identified in the source list.
- Ticker / security symbols
- KVUE [1]
- Listing exchanges
- NYSE [1]
- SEC industry
- Perfumes, Cosmetics & Other Toilet Preparations [1]
- Company / filing name
- Kenvue Inc. [1]
- Business address
- 1 KENVUE WAY, SUMMIT, NJ, 07901 [1]
- Incorporation jurisdiction
- Delaware, United States [1]
- Official website
- www.kenvue.com ↗ [2]
- Fiscal year end
- January 3 (SEC record) [1]
- ISIN (reported securities)
- US49177J1025 [2]
- CIK
- 0001944048 [1]
- SIC code
- 2844 [1]
- Country in background record
- United States [2]
Company positioning and business
Kenvue Inc. is an American consumer health company. Formerly the Consumer Healthcare division of Johnson & Johnson, Kenvue owns well-known brands such as Aveeno, Band-Aid, Benadryl, Zyrtec, Johnson's, Listerine, Lactaid, Mylanta, Neutrogena, Trosyd, Calpol, Tylenol, and Visine. Kenvue is incorporated in Delaware and was originally headquartered in the Skillman section of Montgomery Township, New Jersey, before relocating to Summit, New Jersey. [3]
Johnson & Johnson announced in November 2021 that it would spin off its consumer health division as a separate company. The new company was named Kenvue in September 2022, and its initial public offering took place in May 2023, raising $3.8 billion in the largest U.S. IPO since 2021, with an initial valuation of about $41 billion. Johnson & Johnson initially retained more than 90% ownership before completing a full separation through a share exchange in July 2023. Kenvue was subsequently added to the S&P 500 Dividend Aristocrats index. [3]
CEO Thibaut Mongon initially led Kenvue, which employed about 22,200 people in 2022. Following Mongon’s termination in 2025, Kirk Perry was named interim CEO. Perry was appointed the company's permanent CEO in November 2025. [3]
Background text: Wikipedia contributors, Kenvue. Selected introductory paragraphs, licensed under CC BY-SA 4.0. Official filing data is cited separately.
Financial year, securities and disclosures
The SEC submissions record gives Kenvue Inc. a fiscal year end of 0103 (MMDD). Individual filings below identify their own reporting period; the filing date is the publication event, not the financial year end. [1]
Listed securities: KVUE (NYSE). Multiple symbols may represent different share classes or securities of the same registrant. [4]
History and key events
Form 10-K filed; reporting period ends 2025-12-28. [5]
Financial results and regulatory disclosures
Annual, quarterly and current reports from the collected SEC record. Insider Forms 4 and 144 are excluded. This is a selected list, not a live filing feed.
Source-verified relationships
Companies in the same industry
Comparison candidates share the SEC SIC classification 2844. This does not imply ownership, partnership or trading relationships.
Related entities and concepts
Frequently asked questions
Which industry classification does the SEC report for Kenvue Inc.?
The submissions record lists Perfumes, Cosmetics & Other Toilet Preparations, SIC 2844. [1]
Where can the financial reports of Kenvue Inc. be read?
The financial disclosures section links to collected annual, quarterly and current reports. The SEC source provides the broader filing record. [4]
Kenvue Inc. relationship map
Select a node to inspect its relationship and source.
2 verified direct relationships. Industry peers are not relationship edges.
Sources and review dates
- SEC — Kenvue Inc. filing identity and securities ↗
- Wikidata — company background record (CC0) ↗
- Wikipedia contributors — Kenvue (CC BY-SA 4.0) ↗
- SEC securities directory ↗
- Company chronology / filing ↗
Reviewed 23 October 2026. Financial periods and historical event dates are shown separately. Figures reflect their stated source dates; this page is not a live quote or investment recommendation.